Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study |
| |
Authors: | Stephen R. Marder,Michelle Kramer,Els Eerdekens,Marië lle Eerdekens |
| |
Affiliation: | a Veteran’s Affairs Veteran’s Integrated Service Networks 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, California b Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, California c Johnson & Johnson Pharmaceutical Research and Development, Titusville, New Jersey d Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium e Comprehensive NeuroScience, Inc., Washington, D.C. |
| |
Abstract: | |
| |
Keywords: | Atypical antipsychotic efficacy paliperidone ER schizophrenia tolerability |
本文献已被 ScienceDirect 等数据库收录! |
|